The results of the phase 3 MajesTEC-9 trial showcase teclistamab's efficacy for patients with relapsed/refractory multiple ...

Patients with moderate to severe allergic rhinitis (AR) often experience years of uncontrolled symptoms, worsened quality of ...

Anlotinib combined with chemotherapy showed a 30.8% ORR and 82.7% DCR in advanced STS patients, indicating promising efficacy ...

Research reveals that socioeconomic status significantly impacts survival rates in young adults with metastatic colorectal ...

The panel discussion, “Innovations in Breast Cancer Treatment,” examined the challenge of maintaining or increasing access to care as breast cancer treatment becomes more stratified through biomarker ...

CCCA patients experience longer diagnostic delays, with a mean TTD of 5.67 years, compared to other scarring alopecias. Black patients face longer diagnostic delays, but alopecia subtype is the only ...

A multistakeholder study explores how law enforcement presence in EDs affects survivors of violence and outlines ...

Early phase 1 data suggest that in vivo, off-the-shelf CAR T therapy may be feasible in multiple myeloma, offering the ...

IPF-associated cough affects up to 80% of patients with IPF, substantially impairing their quality of life; consequently, ...

Michael Wang, MD, highlights standout translational studies from ASH 2025 that advance understanding of prognosis and drug ...

Michael Wang, MD, highlights ASH 2025 data showing how continual innovation across targeted agents, cellular and immune ...

Federal homelessness prevention programs, like VA SSVF, improve health outcomes and reduce healthcare costs for veterans.